Page 13 - System Tracker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

One fast-moving lawsuit seeks to block the U.S. government from even starting the drug-price negotiation process.

View the Messenger Inquirer for Saturday, August 19, 2023

The Biden administration is preparing to announce the first 10 medicines it will target under a program that allows the government to negotiate drug prices with pharmaceutical giants, part of a sweep...

A class of drugs initially approved for diabetes treatment has captured the public’s and policymakers’ attention as interest in their off-label use for weight loss rises. The weight-loss benefits of these drugs have led to their prescribed use for obesity or overweight treatment. A new analysis compares list prices for semaglutide—including Ozempic, which has been<span class="readmore-ellipsis">…</span><a href="https://www.kff.org/health-costs/issue-brief/how-do-prices-of-drugs-for-weight-loss-in-the-u-s-compare-to-peer-nations-prices/" class=&qu...

The list is expected to arrive within the next two weeks, and industry experts believe it will include some of the most widely prescribed treatments for arthritis, blood disorders, heart disease and diabetes.